WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael G. GreyDirector2025-11-2150,000$70.00
$3.50MSell
Michael G. GreyDirector2025-11-2150,000$2.94
$146.80kBuy
Christopher PeetzCHIEF EXECUTIVE OFFICER2025-11-1819,133$19.24
$368.12kBuy
Eric BjerkholtCHIEF FINANCIAL OFFICER2025-09-129,578$76.01
$728.02kSell
Laura BregeDirector2025-09-111,491$75.07
$111.93kSell
Laura BregeDirector2025-09-1117,000$15.00
$255.00kBuy
Laura BregeDirector2025-09-1115,509$74.34
$1.15MSell
Saira RamasastryDirector2025-09-0817,000$23.51
$399.67kBuy
Eric BjerkholtCHIEF FINANCIAL OFFICER2025-08-122,954$26.49
$78.25kBuy
Christopher PeetzCHIEF EXECUTIVE OFFICER2025-08-1140,000$62.00
$2.48MSell

1 of 6

MIRM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP13.22%6,795,121$487.62MInstitution
Janus Henderson Group PLC9.72%4,997,586$358.63MInstitution
David M. Mott8.15%4,186,243$300.40MInsider
Peter W. Sonsini8.15%4,186,243$300.40MInsider
Joshua Makower8.15%4,186,243$300.40MInsider
Peter J. Barris8.15%4,186,243$300.40MInsider
Patrick J. Heron7.28%3,741,287$268.47MInsider
Blackrock Inc7.01%3,602,434$258.51MInstitution
Frazier Life Sciences IX LP6.94%3,566,912$255.96MInsider
James E. Flynn6.31%3,244,434$232.82MInsider

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM52.35%47.65%Net SellingNet Buying
VCYT67.80%32.20%Net SellingNet Selling
ARQT76.70%23.30%Net SellingNet Selling
CNTA90.29%9.71%Net SellingNet Selling
CGON84.77%15.23%Net BuyingNet Buying
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 111.58% institutional shareholders, 101.58% Mirum Pharmaceuticals insiders, and 0.00% retail investors. David M. Mott is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 8.15% of the company. David M. Mott's Mirum Pharmaceuticals shares are currently valued at $306.14M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.